Lipodystrophy, Congenital Generalized, Type 2 (CGL2)

Lipodystrophy, Congenital Generalized, Type 2(来自ICD-11)

别称:

Congenital Generalized Lipodystrophy Type 2

Cgl2

Berardinelli-Seip Congenital Lipodystrophy Type 2

Total Lipodystrophy and Acromegaloid Gigantism

Brunzell Syndrome Bscl2-Related

Berardinelli-Seip Syndrome

Lipodystrophy, Berardinelli-Seip Congenital, Type 2

Berardinelli-Seip Congenital Lipodystrophy, Type 2

Lipodystrophy, Total, and Acromegaloid Gigantism

Congenital Generalized Lipodystrophy 2

Familial Partial Lipodystrophy, Type 2

Familial Generalized Lipodystrophy

Lipoatrophic Diabetes, Congenital

Brunzell Syndrome, Bscl2-Related

Congenital Lipoatrophic Diabetes

Lipodystrophy Berardinelli Type

Lipoatrophic Diabetes Mellitus

Lipoatrophic Diabetes

Berardinelli Syndrome

Seip Syndrome

加入收藏

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Lipodystrophy, Congenital Generalized, Type 2, also known as congenital generalized lipodystrophy type 2, is related to lipodystrophy, congenital generalized, type 1 and lipodystrophy, congenital generalized, type 3, and has symptoms including myalgia An important gene associated with Lipodystrophy, Congenital Generalized, Type 2 is BSCL2 (BSCL2 Lipid Droplet Biogenesis Associated, Seipin), and among its related pathways/superpathways are Metabolism and Glucose / Energy Metabolism. The drugs Empagliflozin and Hypoglycemic Agents have been mentioned in the context of this disorder. Affiliated tissues include bone and liver, and related phenotypes are acanthosis nigricans and reduced subcutaneous adipose tissue

查看原文参与反馈